A phase Ib study of combination Regorafenib with PF-03446962 in patient with refactory metastatic colorectal cancer or GIST.

Clinical Trial Grant

Duke Scholars

Principal Investigator Jeffrey Melson Clarke Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Pfizer, Inc.

Start Date

January 1, 2013

End Date

September 30, 2019

Administered By

Duke Cancer Institute

Awarded By

Pfizer, Inc.

Start Date

January 1, 2013

End Date

September 30, 2019